← Eichor
Condition: Hospital Acquired Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hospital Acquired Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Phase 3 · 28 location(s) · Jena University Hospital · NCT06134492Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07388394AI-Driven Prediction of Hospital-Acquired Infections With EHR
Phase N/A · 2 location(s) · The Eye Hospital of Wenzhou Medical University · NCT06791382Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotyp
Phase 3 · 26 location(s) · Nantes University Hospital · NCT06269900Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
NA · 2 location(s) · University Hospital Bispebjerg and Frederiksberg · NCT07189260Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneu
NA · 5 location(s) · Nantes University Hospital · NCT06602934#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-i
NA · 28 location(s) · Casper Rokx · NCT06900829Predictors and Outcomes of Ventilated Hospital-acquired Pneumonia
Phase N/A · 1 location(s) · Assiut University · NCT07667582Transmission of ESBL-producing Enterobacteriaceae
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT03465683Nosocomial Respiratory Virus Infection
NA · 4 location(s) · Hospices Civils de Lyon · NCT06643039Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
NA · 2 location(s) · University of California, Berkeley · NCT06824350HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NA · 1 location(s) · Instituto de Assistencia Medica ao Servidor Publico Estadual · NCT05354778A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte
Phase N/A · 12 location(s) · Innoviva Specialty Therapeutics · NCT06746883Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NA · 1 location(s) · Brigham and Women's Hospital · NCT05389904Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NA · 5 location(s) · Johns Hopkins University · NCT05671718Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients
Phase N/A · 1 location(s) · Valeriu Gheorghita · NCT07134270EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Phase 4 · 4 location(s) · National University of Singapore · NCT05979545Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clini
Phase N/A · 6 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06916481HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
NA · 4 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05952648Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
Phase N/A · 2 location(s) · Sir Run Run Shaw Hospital · NCT07268560Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae I
NA · 15 location(s) · Southeast University, China · NCT06051513Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
NA · 3 location(s) · Ottawa Hospital Research Institute · NCT06103500A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Phase N/A · 1 location(s) · Pfizer · NCT05733104NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766Closed-blood Sampling Devices in the Adult Critically Ill Patient
NA · 3 location(s) · University of Barcelona · NCT06478160A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infecti
Phase 1 · 4 location(s) · Innoviva Specialty Therapeutics · NCT06801223Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infecti
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07089186Optimising TREATment for Severe Gram-Negative Bacterial Infections
Phase 4 · 41 location(s) · National University of Singapore · NCT07004049
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.